ANTX
AN2 Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
AN2 Therapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
AN2 Therapeutics, Inc.
4.50
Fund move
Fund move
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Vivo CapitalVivo Capital | $15.3M | 12.83% | 0.00% | |
| 2 | Commodore CapitalCommodore Capital | $14.2M | 11.93% | +25.71% | |
| 3 | Millennium ManagementMillennium | $11.2M | 9.43% | +4.33% | |
| 4 | BlackRockBlackRockindex-like | $8.1M | 6.77% | +422.48% | |
| 5 | Spruce Street CapitalSpruce Street Capital | $8.0M | 6.76% | 0.00% | |
| 6 | Almitas CapitalAlmitas Capital | $7.1M | 5.98% | −0.68% | |
| 7 | Vanguard Capital ManagementVanguardindex-like | $6.0M | 5.04% | +22.51% | |
| 8 | Adage Capital Partners GPAdage Capital Partners GP | $4.8M | 4.07% | 0.00% | |
| 9 | Citadel AdvisorsCitadel | $4.6M | 3.87% | +513.25% | |
| 10 | Boxer Capital ManagementBoxer | $3.6M | 3.05% | 0.00% | |
| 11 | Geode Capital ManagementGeodeindex-like | $3.4M | 2.84% | +143.52% | |
| 12 | SummitTX CapitalSummitTX Capital | $2.9M | 2.43% | new | |
| 13 | Balyasny Asset ManagementBalyasny | $2.7M | 2.26% | new | |
| 14 | Stonepine Capital ManagementStonepine | $2.7M | 2.24% | −22.72% | |
| 15 | Ameriprise FinancialAmeriprise Financial | $2.6M | 2.18% | −22.86% | |
| 16 | Sio Capital ManagementSio | $2.6M | 2.16% | −19.37% | |
| 17 | Ally Bridge Group (NY)Ally Bridge Group (NY) | $2.5M | 2.14% | 0.00% | |
| 18 | Prosight ManagementProsight | $2.3M | 1.93% | −7.97% | |
| 19 | Woodline PartnersWoodline Partners | $2.2M | 1.87% | −53.73% | |
| 20 | State StreetState Streetindex-like | $1.5M | 1.27% | +170.48% | |
| 21 | Northern TrustNorthern Trustindex-like | $1.0M | 0.87% | +397.55% | |
| 22 | Seven Fleet Capital ManagementSeven Fleet | $1.0M | 0.85% | +4.63% | |
| 23 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $953,093 | 0.80% | +43.00% | |
| 24 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $869,235 | 0.73% | new | |
| 25 | Landscape Capital ManagementLandscape | $810,438 | 0.68% | −43.84% |
66 managers report $119.0M of AN2 Therapeutics on form 13F for the quarter ended Jun 30 '26. 15 of them hold 80% of it; Vivo Capital is largest at 12.83%.
Expected move
No implied move.
No implied move.
No implied move.